SetPoint Medical Presents 24-Month Data Demonstrating Sustained Clinical Benefit and Favorable Long-Term Safety of the SetPoint® System for Rheumatoid Arthritis
Findings presented at ACR Convergence 2026 reinforce the long-term potential of neuroimmune modulation as a durable treatment approach for people living with rheumatoid arthritis SANTA CLARITA, Calif., Nov. 9, 2026 /PRNewswire/ -- SetPoint Medical, a company dedicated to developing...